NASDAQ:CMRX

Chimerix News Headlines

$8.31
+0.14 (+1.71 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.96
Now: $8.31▼
$8.39
50-Day Range
$8.17
MA: $9.47▼
$10.67
52-Week Range
$1.37
Now: $8.31▼
$11.57
Volume489,814 shs
Average Volume1.19 million shs
Market Capitalization$711.99 million
P/E RatioN/A
Dividend YieldN/A
Beta1.88

Headlines

Chimerix (NASDAQ CMRX) News Headlines Today

SourceHeadline
Short Interest in Chimerix, Inc. (NASDAQ:CMRX) Grows By 294.2%Short Interest in Chimerix, Inc. (NASDAQ:CMRX) Grows By 294.2%
americanbankingnews.com - April 13 at 8:24 AM
How Many Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) Shares Did Insiders Buy, In The Last Year? - NasdaqHow Many Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) Shares Did Insiders Buy, In The Last Year? - Nasdaq
nasdaq.com - April 12 at 2:20 PM
Investors Who Bought Cimpress (NASDAQ:CMPR) Shares A Year Ago Are Now Up 65% - NasdaqInvestors Who Bought Cimpress (NASDAQ:CMPR) Shares A Year Ago Are Now Up 65% - Nasdaq
nasdaq.com - April 12 at 2:20 PM
Can You Imagine How Elated Chimerixs (NASDAQ:CMRX) Shareholders Feel About Its 458% Share Price Gain? - NasdaqCan You Imagine How Elated Chimerix's (NASDAQ:CMRX) Shareholders Feel About Its 458% Share Price Gain? - Nasdaq
nasdaq.com - April 12 at 2:20 PM
Jonestrading Reiterates "Buy" Rating for Chimerix (NASDAQ:CMRX)Jonestrading Reiterates "Buy" Rating for Chimerix (NASDAQ:CMRX)
americanbankingnews.com - April 12 at 9:18 AM
Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Yahoo FinanceChimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Yahoo Finance
finance.yahoo.com - April 8 at 5:20 PM
Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021
finance.yahoo.com - April 8 at 5:20 PM
What Kind Of Shareholders Hold The Majority In Chimerix, Inc.s (NASDAQ:CMRX) Shares?What Kind Of Shareholders Hold The Majority In Chimerix, Inc.'s (NASDAQ:CMRX) Shares?
finance.yahoo.com - April 8 at 12:19 PM
Chimerix, Inc. (NASDAQ:CMRX) Insider David Jakeman Sells 1,284 SharesChimerix, Inc. (NASDAQ:CMRX) Insider David Jakeman Sells 1,284 Shares
americanbankingnews.com - April 7 at 4:32 PM
Brokerages Expect Chimerix, Inc. (NASDAQ:CMRX) to Announce -$0.59 EPS Brokerages Expect Chimerix, Inc. (NASDAQ:CMRX) to Announce -$0.59 EPS
americanbankingnews.com - April 7 at 12:16 PM
Chimerix, Inc. Expected to Earn Q1 2021 Earnings of ($0.16) Per Share (NASDAQ:CMRX)Chimerix, Inc. Expected to Earn Q1 2021 Earnings of ($0.16) Per Share (NASDAQ:CMRX)
americanbankingnews.com - April 2 at 8:00 AM
Analysts Issue Forecasts for Chimerix, Inc.s Q1 2021 Earnings (NASDAQ:CMRX)Analysts Issue Forecasts for Chimerix, Inc.'s Q1 2021 Earnings (NASDAQ:CMRX)
americanbankingnews.com - April 2 at 8:00 AM
Chimerix (NASDAQ:CMRX) Shares Gap Up to $8.59Chimerix (NASDAQ:CMRX) Shares Gap Up to $8.59
americanbankingnews.com - March 31 at 10:58 AM
UPDATE: Jefferies Starts Chimerix (CMRX) at Buy - StreetInsider.comUPDATE: Jefferies Starts Chimerix (CMRX) at Buy - StreetInsider.com
streetinsider.com - March 31 at 9:42 AM
Chimerix (NASDAQ:CMRX) Receives New Coverage from Analysts at Jefferies Financial GroupChimerix (NASDAQ:CMRX) Receives New Coverage from Analysts at Jefferies Financial Group
americanbankingnews.com - March 31 at 8:36 AM
Chimerix (NASDAQ:CMRX) Earns Outperform Rating from Analysts at WedbushChimerix (NASDAQ:CMRX) Earns Outperform Rating from Analysts at Wedbush
americanbankingnews.com - March 31 at 8:36 AM
-$1.10 Earnings Per Share Expected for Chimerix, Inc. (NASDAQ:CMRX) This Quarter-$1.10 Earnings Per Share Expected for Chimerix, Inc. (NASDAQ:CMRX) This Quarter
americanbankingnews.com - March 21 at 4:12 AM
Emerging Drugs for the Acute Lung Injury Treatment: A Focus on Recent Clinical Trials - GlobeNewswireEmerging Drugs for the Acute Lung Injury Treatment: A Focus on Recent Clinical Trials - GlobeNewswire
globenewswire.com - March 16 at 12:43 AM
Chimerix to Present at Virtual H.C. Wainwright Global Life Sciences Conference - GlobeNewswireChimerix to Present at Virtual H.C. Wainwright Global Life Sciences Conference - GlobeNewswire
globenewswire.com - March 2 at 8:39 AM
Chimerix to Present at Virtual H.C. Wainwright Global Life Sciences ConferenceChimerix to Present at Virtual H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 8:39 AM
Durham pharma CEOs still juggling Covid challenges, opportunities - Triangle Business Journal - Triangle Business JournalDurham pharma CEOs still juggling Covid challenges, opportunities - Triangle Business Journal - Triangle Business Journal
bizjournals.com - February 28 at 4:50 PM
Chimerixs DSTAT Shows Promising Results In First Cohort Of COVID-19 Study - Yahoo FinanceChimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study - Yahoo Finance
finance.yahoo.com - February 27 at 1:27 AM
Chimerix (CMRX) CEO Mike Sherman on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaChimerix' (CMRX) CEO Mike Sherman on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 26 at 8:27 PM
Chimerix (CMRX) Q4 2020 Earnings Call TranscriptChimerix (CMRX) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 26 at 10:26 AM
Chimerix (CMRX) Q4 2020 Earnings Call Transcript - Motley FoolChimerix (CMRX) Q4 2020 Earnings Call Transcript - Motley Fool
fool.com - February 25 at 11:36 PM
Chimerix (CMRX) Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT - StreetInsider.comChimerix (CMRX) Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT - StreetInsider.com
streetinsider.com - February 25 at 1:34 PM
Chimerixs DSTAT Shows Promising Results In First Cohort Of COVID-19 StudyChimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study
finance.yahoo.com - February 25 at 1:34 PM
Chimerix EPS beats by $0.01, misses on revenue - Seeking AlphaChimerix EPS beats by $0.01, misses on revenue - Seeking Alpha
seekingalpha.com - February 25 at 8:34 AM
Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT - GlobeNewswireChimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT - GlobeNewswire
globenewswire.com - February 25 at 8:34 AM
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update - GlobeNewswireChimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update - GlobeNewswire
globenewswire.com - February 25 at 8:34 AM
Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTATChimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT
finance.yahoo.com - February 25 at 8:34 AM
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational UpdateChimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
finance.yahoo.com - February 25 at 8:34 AM
Steven Cohen Dives Into Chimerix - Yahoo FinanceSteven Cohen Dives Into Chimerix - Yahoo Finance
finance.yahoo.com - February 24 at 12:26 PM
Chimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021 - Yahoo FinanceChimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021 - Yahoo Finance
finance.yahoo.com - February 19 at 2:20 PM
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout - Yahoo FinanceThe Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout - Yahoo Finance
finance.yahoo.com - February 18 at 6:43 PM
Chimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021 - GlobeNewswireChimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021 - GlobeNewswire
globenewswire.com - February 18 at 1:43 PM
Chimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021Chimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021
finance.yahoo.com - February 18 at 8:43 AM
Intercept Appoints Linda Richardson as Chief Commercial Officer - StreetInsider.comIntercept Appoints Linda Richardson as Chief Commercial Officer - StreetInsider.com
streetinsider.com - February 17 at 7:11 PM
Chimerix: Recent Acquisition Gives This Laggard Antiviral Company A Fresh Start In Oncology - Seeking AlphaChimerix: Recent Acquisition Gives This Laggard Antiviral Company A Fresh Start In Oncology - Seeking Alpha
seekingalpha.com - February 15 at 7:49 AM
Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares - GlobeNewswireChimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares - GlobeNewswire
globenewswire.com - January 25 at 7:44 PM
Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional SharesChimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
finance.yahoo.com - January 25 at 7:44 PM
Chimerix (CMRX) prices $100M share offering - Seeking AlphaChimerix (CMRX) prices $100M share offering - Seeking Alpha
seekingalpha.com - January 22 at 12:49 AM
Biopharma Chimerix eyes $100 million stock offering as share price leaps - Triangle Business JournalBiopharma Chimerix eyes $100 million stock offering as share price leaps - Triangle Business Journal
bizjournals.com - January 22 at 12:49 AM
Chimerix Announces Pricing of Public Offering of Common Stock - GlobeNewswireChimerix Announces Pricing of Public Offering of Common Stock - GlobeNewswire
globenewswire.com - January 20 at 8:43 PM
Chimerix Announces Pricing of Public Offering of Common StockChimerix Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 20 at 8:43 PM
Chimerix Announces Proposed $75000000 Public Offering of Common Stock - GlobeNewswireChimerix Announces Proposed $75000000 Public Offering of Common Stock - GlobeNewswire
globenewswire.com - January 20 at 12:02 AM
Chimerix Announces Proposed $75,000,000 Public Offering of Common StockChimerix Announces Proposed $75,000,000 Public Offering of Common Stock
finance.yahoo.com - January 19 at 7:01 PM
82 Biggest Movers From Friday - Benzinga82 Biggest Movers From Friday - Benzinga
benzinga.com - January 11 at 12:39 PM
Company News for Jan 11, 2021 - NasdaqCompany News for Jan 11, 2021 - Nasdaq
nasdaq.com - January 11 at 12:39 PM
Company News for Jan 11, 2021Company News for Jan 11, 2021
finance.yahoo.com - January 11 at 12:39 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.